Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity and safety of the SARS-CoV-2 mRNA vaccine CVnCoV in elderly vs younger adults was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019
• Respiratory Syndrome

Drugs mentioned

• CVnCoV (CVnCoV)

Snippet

Sponsor: CureVac | Conditions: Coronavirus, Covid19 | Phase 3 | Status: WITHDRAWN